|
 |
 |
 |
C. Garrison Fathman, MD, Director and Founder
Dr. Fathman is Professor of Medicine and Chief of the Division of Immunology and Rheumatology at Stanford University School of Medicine and is also director of the Center for Clinical Immunology at Stanford (CCIS). Dr. Fathman received his M.D. from Washington University in St. Louis and did his residency training at Dartmouth Affiliated Hospitals and a fellowship in immunology and rheumatology at Stanford University before completing an additional 4 years of basic immunology research at the NIH and Basel . He then joined the faculty at the Mayo Clinic in 1977 and was recruited to Stanford University in 1981. There he continues his seminal work on T cell activation and regulation in association with autoimmune diseases. Dr. Fathman has published over 250 articles in his field and is a member of many professional organizations, including the American Association of Immunologists and the Association of American Physicians, and is founding Chairman of the Federation of Clinical Immunology Societies (FOCIS). He was a co-founder of Cetus Immune, Immulogic and CellGate, and has served on the SAB of multiple companies.
|
 |
Michael Danaher, JD, Director
Mike Danaher is a partner in the law firm of Wilson Sonsini Goodrich & Rosati, Michael Danaher works with private and public emerging growth companies in the life sciences and other high technology industries. He handles general corporate matters and transactions, including private financings, public offerings, mergers and acquisitions. Mr. Danaher graduated from Yale College in 1975 and from Stanford Law School in 1980. |
 |
Peter A. Altman, PhD, Director
Peter is CEO of BioCardia, Inc. (1999 to present) where he has global responsibility for the development, manufacture and marketing of local cardiovascular drug delivery and vascular access catheter systems. He was acting CEO for Lumen Therapeutics (2003-2005). Peter was also founding CEO for Expression Diagnostics, Inc. (2000- 2003) a developer of a gene based diagnostic assay platform to be used in chronic inflammatory diseases and an inventor of the technology that is being developed by medical device start up Sinus Rhythm Technologies, Inc. Peter has 19 years experience in life science research and product development, is named inventor of 25 US patents, and has authored 25 scientific publications. Peter received his PhD in Bioengineering/ Pharmaceutical Chemistry from the University of California San Francisco and University of California Berkeley, his Management of Technology certificate from the Haas School of Business, University of California Berkeley, and both his Master of Science and Bachelors of Science degrees in Mechanical Engineering from the Columbia University School of Engineering and Applied Sciences. |
|
|
